Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepa Bhojwani

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Personalized Medicine|May 24, 2018
Individualized therapy for childhood acute lymphoblastic leukemiaElizabeth A Raetz, Deepa Bhojwani, Dong-Joon Min, et al.
Pediatric Blood & Cancer|September 7, 2017
Association of clinical trial enrollment and survival using contemporary therapy for pediatric acute lymphoblastic leukemiaDiana J Moke, Matthew J Oberley, Deepa Bhojwani, et al.
Clinical Pharmacology and Therapeutics|November 24, 2023
Developing Therapy for Every Kid With Cancer - Summary of a Scientific Session at the 2023 ASCPT MeetingJason N Moore, Olivia Campagne, Deepa Bhojwani, et al.
Pediatric Blood & Cancer|December 21, 2005
Childhood acute lymphoblastic leukemia in the age of genomicsWilliam L Carroll, Deepa Bhojwani, Dong-Joon Min, et al.
Pediatric Blood & Cancer|December 9, 2017
Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimensChristopher C Denton, Yasmin A Rawlins, Matthew J Oberley, et al.
Pediatric Blood & Cancer|April 18, 2024
IKZF1<sup>PLUS</sup> alterations contribute to outcome disparities in Hispanic/Latino children with B-lymphoblastic leukemiaAlexandra E Kovach, Maximilian Wengyn, My H Vu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemiaSharon Wu, Mengxi Wang, Amani Alqahtani, et al.
British Journal of Haematology|June 10, 2010
Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemiaFrancis Mussai, Dario Campana, Deepa Bhojwani, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 6, 2023
Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understandingAmani Alqahtani, Diala Alhousari, Amir Ali, et al.
Pharmacogenetics and Genomics|October 29, 2024
Budget impact analysis of TPMT and NUDT15 pharmacogenomic testing for 6-mercaptopurine in pediatric acute lymphoblastic leukemia patientsBeverly Fuerte, Mia Burgos, Vyvy Cao, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Personalized Medicine|May 24, 2018
Individualized therapy for childhood acute lymphoblastic leukemiaElizabeth A Raetz, Deepa Bhojwani, Dong-Joon Min, et al.
Pediatric Blood & Cancer|September 7, 2017
Association of clinical trial enrollment and survival using contemporary therapy for pediatric acute lymphoblastic leukemiaDiana J Moke, Matthew J Oberley, Deepa Bhojwani, et al.
Clinical Pharmacology and Therapeutics|November 24, 2023
Developing Therapy for Every Kid With Cancer - Summary of a Scientific Session at the 2023 ASCPT MeetingJason N Moore, Olivia Campagne, Deepa Bhojwani, et al.
Pediatric Blood & Cancer|December 21, 2005
Childhood acute lymphoblastic leukemia in the age of genomicsWilliam L Carroll, Deepa Bhojwani, Dong-Joon Min, et al.
Pediatric Blood & Cancer|December 9, 2017
Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimensChristopher C Denton, Yasmin A Rawlins, Matthew J Oberley, et al.
Pediatric Blood & Cancer|April 18, 2024
IKZF1<sup>PLUS</sup> alterations contribute to outcome disparities in Hispanic/Latino children with B-lymphoblastic leukemiaAlexandra E Kovach, Maximilian Wengyn, My H Vu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemiaSharon Wu, Mengxi Wang, Amani Alqahtani, et al.
British Journal of Haematology|June 10, 2010
Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemiaFrancis Mussai, Dario Campana, Deepa Bhojwani, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 6, 2023
Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understandingAmani Alqahtani, Diala Alhousari, Amir Ali, et al.
Pharmacogenetics and Genomics|October 29, 2024
Budget impact analysis of TPMT and NUDT15 pharmacogenomic testing for 6-mercaptopurine in pediatric acute lymphoblastic leukemia patientsBeverly Fuerte, Mia Burgos, Vyvy Cao, et al.
Pageof 13